ESC 365 - Thirty-day clinical outcomes after an atrial flutter ablation in patients on dabigatran: the STUDY FLUTTER French prospective study

EHRA Premium Access

Thirty-day clinical outcomes after an atrial flutter ablation in patients on dabigatran: the STUDY FLUTTER French prospective study

Session: Poster session 1 - Atrial Fibrillation - Stroke Prevention

Topic: Oral Anticoagulation

Speaker: Miss D. Mlayeh (Aulnay sous Bois, FR)

Event: EHRA 2019

Congress Presentation

Add to my library

About the speaker

Miss Dorsaf Mlayeh

Hopital Robert Ballanger, Aulnay sous Bois (France)

0 follower

10 more presentations in this session

Single-centre experience of percutaneous left atrial appendage closure using the lifetech lambre device for thromboembolic prevention in patients with atrial fibrillation.

Speaker: Associate Professor K. Neven (Essen, DE)

Perception on anticoagulant treatment and treatment convenience for patients switching from a vitamin K antagonist to dabigatran for stroke prophylaxis in atrial fibrillation (RE-SONANCE study)

Speaker: Doctor R. Tieleman (Groningen, NL)

Left atrial appendage occlusion using novel lambre, amulet and watchman in atrial fibrillation

Speaker: Doctor S. Chen (Greifswald, DE)

Thirty-day clinical outcomes after rhythmology procedures in patients with non-valvular atrial fibrillation on apixaban: Results of the AMPER AF study

Speaker: Professor J. Mansourati (Brest, FR)

Vitamin-K antagonists vs. NOAC for resolution of left atrial appendage thrombus in patients with atrial fibrillation.

Speaker: Doctor N. Wainstejn (Berlin, DE)

Access the full session

Poster session 1 - Atrial Fibrillation - Stroke Prevention

Speakers: Miss D. Mlayeh, Associate Professor K. Neven, Doctor R. Tieleman, Doctor S. Chen, Professor J. Mansourati...

About the event

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources